Home › Research › Digital health tools
The Ontario Neurodegenerative Disease Research Initiative (ONDRI)
Farhan SM, Bartha R, Black SE, Corbett D, Finger E, Freedman M, Greenberg B, Grimes DA et al.. The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 2016-12-22
Topic: Risk, prevention and care in population studies
Plain-language summary
Because individuals develop dementia as a manifestation of neurodegenerative or neurovascular disorder, there is a need to develop reliable approaches to their identification. We are undertaking an observational study (Ontario Neurodegenerative Disease Research Initiative [ONDRI]) that includes genomics, neuroimaging, and assessments of cognition as well as language, speech, gait, retinal imaging, and eye tracking. Disorders studied include Alzheimer's disease, amyotrophic lateral sclerosis, frontotemporal dementia, Parkinson's disease, and vascular cognitive impairment. Data from ONDRI will be collected into the Brain-CODE database to facilitate correlative analysis. ONDRI will provide a repertoire of endophenotyped individuals that will be a unique, publicly available resource.
What this study adds
Evidence grade: Low
This observational study describes a research initiative collecting genomic, imaging, and cognitive data across several neurodegenerative disorders to improve their identification. It is a study design and resource description and does not test any treatment, cure, or prevention for Alzheimer's disease.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Farhan, S. M., Bartha, R., Black, S. E., Corbett, D., Finger, E., Freedman, M., et al. (2017). The Ontario Neurodegenerative Disease Research Initiative (ONDRI). The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques. https://doi.org/10.1017/cjn.2016.415
Vancouver
Farhan SM, Bartha R, Black SE, Corbett D, Finger E, Freedman M, et al. The Ontario Neurodegenerative Disease Research Initiative (ONDRI). The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques. 2017. doi:10.1017/cjn.2016.415. PMID: 28003035.
BibTeX
@article{farhan2017-28003035,
author = {Farhan, S. M. and Bartha, R. and Black, S. E. and Corbett, D. and Finger, E. and Freedman, M. and Greenberg, B. and Grimes, D. A. and others},
title = {{The Ontario Neurodegenerative Disease Research Initiative (ONDRI)}},
journal = {The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques},
year = {2017},
doi = {10.1017/cjn.2016.415},
pmid = {28003035},
url = {https://doi.org/10.1017/cjn.2016.415}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- Because individuals develop dementia as a manifestation of neurodegenerative or neurovascular disorder, there is a need to develop reliable approaches to their identification.
- We are undertaking an observational study (Ontario Neurodegenerative Disease Research Initiative [ONDRI]) that includes genomics, neuroimaging, and assessments of cognition as well as language, speech, gait, retinal imaging, and eye tracking.
- Disorders studied include Alzheimer's disease, amyotrophic lateral sclerosis, frontotemporal dementia, Parkinson's disease, and vascular cognitive impairment.
- Data from ONDRI will be collected into the Brain-CODE database to facilitate correlative analysis.
- ONDRI will provide a repertoire of endophenotyped individuals that will be a unique, publicly available resource.
Why it matters
This observational study describes a research initiative collecting genomic, imaging, and cognitive data across several neurodegenerative disorders to improve their identification. It is a study design and resource description and does not test any treatment, cure, or prevention for Alzheimer's disease.
New to this subject? Start with our plain-English guide: Digital health →
Study details
- Evidence strengthLow
How this study scored 49/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques) |
| Journal's citation record | 1 / 4 | Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques: journal h-index 121 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 2 / 5 | 2017 — within 10 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 3 / 3 | Studied in people (pubmed indexes it as a clinical or observational study) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 5 / 7 | Cited 104 times (OpenAlex, 2026-10-10) |
| Citations per year | 3 / 5 | 9.5 citations a year over 11 year(s) since 2017 |
| Impact for its field and year | 3 / 6 | Cited 5.2× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 2 / 6 | Cited by 3 other studies in this library |
| Still being cited | 2 / 4 | Cited 31 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 3 / 4 | Last-listed author Michael Joseph Strong: h-index 67 (OpenAlex, whole career) |
| Institution's track record | 2 / 3 | University of Toronto: institution h-index 1,923 (OpenAlex) |
| Multicenter collaboration | 3 / 3 | OpenAlex lists 18 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 28003035) |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Total | 49 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.1017/cjn.2016.415
- PubMed: 28003035
- Original source →
- Free full text: Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Later studies that cite this one
3 studies in the alzhub library list this one in their references.
Related studies in Digital health tools from nearby years
Also in Digital health tools
178 studies in the library are filed under Digital health tools with no topic tag they share with another; these are this study's neighbours in a fixed tour of them. The Digital health tools hub.